Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | PNMT | P11086 | 1/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 7/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5326981 | 0.81 | TSHR (0.38) | TSHRLMNAPNMTP2RX7MEN1 | |
| SCHEMBL22915607 | 0.78 | ESR1 (0.41) | TSHRLMNAPNMTP2RX7MEN1 | |
| SCHEMBL2103502 | 0.75 | TSHR (0.44) | TSHRLMNAPNMTMEN1KMT2A | |
| SCHEMBL9932121 | 0.71 | TSHR (0.41) | TSHRLMNAPNMTIDO1CYP2A6 | |
| SCHEMBL29120692 | 0.71 | TSHR (0.39) | TSHRLMNAMAPTCYP1A2ALDH1A1 | |
| SCHEMBL76000 | 0.71 | TSHR (0.39) | TSHRLMNAMAPTCYP1A2ALDH1A1 | |
| SCHEMBL8207775 | 0.71 | CYP1A2 (0.41) | TSHRLMNAMAPTCYP2A6CYP1A2 | |
| SCHEMBL31643929 | 0.71 | CYP1A2 (0.41) | TSHRLMNAMAPTCYP2A6CYP1A2 | |
| SCHEMBL4264209 | 0.69 | TDP1 (0.39) | TSHRALDH1A1 | |
| SCHEMBL8372962 | 0.69 | TSHR (0.50) | TSHRLMNAPNMTMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0128721-B1 | SILICA-MODIFIED CATALYST AND USE FOR SELECTIVE PRODUCTION OF PARA-DIALKYL SUBSTITUTED BENZENES | MOBIL OIL CORPORATION (US) | 1989-07-26 | — | — | EP | claimed |
| CN-105283415-B | The in-situ modification coke selectivity of toluene disproportionation catalyst deactivates | 埃克森美孚化学专利公司 | 2017-07-21 | — | — | CN | disclosed |
| CN-105283415-A | In-situ trim coke selectivation of toluene disproportionation catalyst | EXXONMOBIL CHEM PATENTS INC | 2016-01-27 | — | — | CN | disclosed |
| CN-100579942-C | Xylenes isomerization catalyst system and use thereof | EXXONMOBIL CHEM PATENTS INC | 2010-01-13 | — | — | CN | disclosed |
| CN-1989089-A | Xylenes isomerization catalyst system and use thereof | EXXONMOBIL CHEM PATENTS INC (US) | 2007-06-27 | — | — | CN | disclosed |
| CN-1720207-A | Aromatics conversion using ITQ-13 | EXXONMOBIL CHEM PATENTS INC (US) | 2006-01-11 | — | — | CN | disclosed |
| WO-2003059508-A1 | REFORMING CATALYST AND PROCESS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2003-07-24 | — | — | WO | disclosed |
| US-20030136708-A1 | Reforming catalyst and process | EXXONMOBIL RESEARCH & ENGINEERING CO. | 2003-07-24 | — | — | US | disclosed |
| US-6541408-B2 | Progressive temperature gradient stabilizes hydrorefining catalysts (metal-modified zeolite) to allow long duration of use and low by-product make | EXXONMOBIL OIL CORP. | 2003-04-01 | — | — | US | disclosed |
| CN-1379698-A | Zeolite bound catalyst containing at least three different zeolites, and use for hydrocarbon conversion | EXXON MOBIL CHEM PATENTS INC (US) | 2002-11-13 | — | — | CN | disclosed |
| US-20020091293-A1 | Zeolite catalysts having stabilized hydrogenation-dehydrogenation function | EXXONMOBIL OIL CORPORATION | 2002-07-11 | — | — | US | disclosed |
| CN-1356927-A | Metal-contg. macrostructures of porous inorganic oxide, prepn. thereof, and use | EXXON CHEMICAL PATENTS INC (US) | 2002-07-03 | — | — | CN | disclosed |
| US-6346498-B1 | PERMEATING METAL INTO MOLECULAR SIEVE; IN SITU SELECTIVATION WITH SILICON COMPOUND AND ROASTING; BY-PRODUCT INHIBITION | EXXONMOBIL OIL CORPORATION | 2002-02-12 | — | — | US | disclosed |
| US-6207871-B1 | CONVERTING A HYDROCARBON FEEDSTREAM COMPRISING ETHYLBENZENE AND META-XYLENE OVER MOLECULAR SIEVE CATALYST UNDER ETHYLBENZENE CONVERSION CONDITIONS, | MOBIL OIL CORPORATION | 2001-03-27 | — | — | US | disclosed |
| US-4532368-A | Passing mixture of phenol, ortho-alkylphenol, alkylating agent through zeolite catalyst, separating and recycling ortho-alkylphenols | ETHYL CORPORATION (US) | 1985-07-30 | — | — | US | disclosed |
| US-4444989-A | Methylation of toluene to para-xylene catalyzed by crystalline silica | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-04-24 | — | — | US | disclosed |
| US-4283306-A | CATALYTIC METHYLATION OF TOLUENE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091293-A1 | Zeolite catalysts having stabilized hydrogenation-dehydrogenation function | HDHD5, HSF1, HRH4 | TSHR 4495/4885LMNA 2396/4885PNMT 923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.